logo-loader
viewAbimmune Biopharma

Abimmune Biopharma aiming to 'significantly elevate' the standard of cancer care

Abimmune Biopharma CEO Flora Fan spoke with Proactive at the Biotech Showcase 2020 in San Francisco. The privately-held, San Diego-based company is developing multi-targeting immuno-oncology protein drugs. According to the company, its lead candidate will reach Investigational New Drug enablement within one year.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Phunware helps new, unnamed railroad customer better engage...

Phunware Inc. (NASDAQ:PHUN) COO Randall Crowder tells Proactive the fully-integrated enterprise cloud platform for mobile has unveiled a first national railway customer for its mobile corporate campus solution. Crowser says the new, unnamed national transportation customer will leverage...

1 hour, 9 minutes ago

2 min read